Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
O'Grady J |
C(2) monitoring: out of the blocks but with some way to go! |
2004 |
Transplantation |
pmid:15201659
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Josephson MA et al. |
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. |
2004 |
Transplantation |
pmid:15502727
|
Yamagami S et al. |
Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. |
1997 |
Transplantation |
pmid:9233699
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
van Hooff JP et al. |
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. |
2003 |
Transplantation |
pmid:12829890
|
Stegall MD et al. |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9422416
|
Donnadieu B et al. |
Central retinal vein occlusion-associated tacrolimus after liver transplantation. |
2014 |
Transplantation |
pmid:25955343
|
Kasahara M et al. |
Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. |
2001 |
Transplantation |
pmid:11211185
|
Ovuworie CA et al. |
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. |
2001 |
Transplantation |
pmid:11685108
|
Mourad G et al. |
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11579299
|
Vacher-Coponat H et al. |
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. |
2006 |
Transplantation |
pmid:16926601
|
Ciancio G et al. |
Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation. |
2011 |
Transplantation |
pmid:22027927
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Shapiro R et al. |
Posttransplant diabetes in pediatric recipients on tacrolimus. |
1999 |
Transplantation |
pmid:10096540
|
Prud'homme GJ et al. |
GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. |
2013 |
Transplantation |
pmid:23851932
|
Nashan B et al. |
Clinical validation studies of Neoral C(2) monitoring: a review. |
2002 |
Transplantation |
pmid:12023607
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Ekberg H et al. |
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. |
2009 |
Transplantation |
pmid:19424036
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Mestres J et al. |
Late subcapsular lymphocele in a kidney graft. |
2012 |
Transplantation |
pmid:22487814
|
Jain A et al. |
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. |
2001 |
Transplantation |
pmid:11374410
|
Cherikh WS et al. |
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. |
2003 |
Transplantation |
pmid:14627905
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Sommerer C et al. |
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. |
2010 |
Transplantation |
pmid:20463649
|
Froud T et al. |
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. |
2008 |
Transplantation |
pmid:19104407
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Verleden GM et al. |
Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. |
2002 |
Transplantation |
pmid:12131703
|
Johnson C et al. |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. |
2000 |
Transplantation |
pmid:10755536
|
Ekser B et al. |
Hepatic function after genetically engineered pig liver transplantation in baboons. |
2010 |
Transplantation |
pmid:20606605
|
Alloway R et al. |
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. |
2007 |
Transplantation |
pmid:17589351
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Dieterle CD et al. |
Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. |
2004 |
Transplantation |
pmid:15239622
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|